Genky DrugStores Co., Ltd. (JP:9267)
:9267
Total Valuation
Genky DrugStores Co., Ltd. has a market cap or net worth of ¥129.69B. The enterprise value is ¥159.76B.
Market Cap¥129.69B
Enterprise Value¥159.76B
Share Statistics
Genky DrugStores Co., Ltd. has 31,031,569 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,031,569
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Genky DrugStores Co., Ltd.’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 7.42%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.42%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee120.88M
Profits Per Employee4.25M
Employee Count1,661
Asset Turnover1.57
Inventory Turnover6.12
Valuation Ratios
The current PE Ratio of Genky DrugStores Co., Ltd. is 19.0. Genky DrugStores Co., Ltd.’s PEG ratio is 1.41.
PE Ratio19.0
PS Ratio0.58
PB Ratio2.17
Price to Fair Value2.17
Price to FCF-46.47
Price to Operating Cash Flow0.00
PEG Ratio1.41
Income Statement
In the last 12 months, Genky DrugStores Co., Ltd. had revenue of 200.79B and earned 7.07B in profits. Earnings per share was 232.49.
Revenue200.79B
Gross Profit35.09B
Operating Income9.66B
Pretax Income9.90B
Net Income7.07B
EBITDA15.95B
Earnings Per Share (EPS)232.49
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Genky DrugStores Co., Ltd. pays an annual dividend of ¥6.5, resulting in a dividend yield of 0.25%
Dividend Per Share¥6.5
Dividend Yield0.25%
Payout Ratio5.26%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change55.45%
50-Day Moving Average4.19K
200-Day Moving Average4.54K
Relative Strength Index (RSI)59.03
Average Volume (3m)62.69K
Important Dates
Genky DrugStores Co., Ltd. upcoming earnings date is Apr 28, 2026, TBA (Confirmed).
Last Earnings DateJan 27, 2026
Next Earnings DateApr 28, 2026
Ex-Dividend Date―
Financial Position
Genky DrugStores Co., Ltd. as a current ratio of 0.94, with Debt / Equity ratio of 61.11%
Current Ratio0.94
Quick Ratio0.32
Debt to Market Cap0.30
Net Debt to EBITDA1.76
Interest Coverage Ratio44.72
Taxes
In the past 12 months, Genky DrugStores Co., Ltd. has paid 2.84B in taxes.
Income Tax2.84B
Effective Tax Rate0.29
Enterprise Valuation
Genky DrugStores Co., Ltd. EV to EBITDA ratio is 9.03, with an EV/FCF ratio of -57.76.
EV to Sales0.72
EV to EBITDA9.03
EV to Free Cash Flow-57.76
EV to Operating Cash Flow11.44
Balance Sheet
Genky DrugStores Co., Ltd. has ¥6.22B in cash and marketable securities with ¥34.37B in debt, giving a net cash position of -¥28.15B billion.
Cash & Marketable Securities¥6.22B
Total Debt¥34.37B
Net Cash-¥28.15B
Net Cash Per Share-¥907.24
Tangible Book Value Per Share¥1.75K
Margins
Gross margin is 20.47%, with operating margin of 4.81%, and net profit margin of 3.52%.
Gross Margin20.47%
Operating Margin4.81%
Pretax Margin4.93%
Net Profit Margin3.52%
EBITDA Margin7.94%
EBIT Margin4.81%
Analyst Forecast
The average price target for Genky DrugStores Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.97%
EPS Growth Forecast16.27%